ASP Isotopes (ASPI) Gains from Sales and Divestitures (2022 - 2025)
ASP Isotopes has reported Gains from Sales and Divestitures over the past 4 years, most recently at $2.9 million for Q4 2025.
- On a quarterly basis, Gains from Sales and Divestitures fell 24.59% to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a 24.59% decrease, with the full-year FY2025 number at $2.9 million, down 24.59% from a year prior.
- Gains from Sales and Divestitures reached $2.9 million in Q4 2025 per ASPI's latest filing, up from $984330.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $3.9 million in Q4 2024, with the low at $350000.0 in Q4 2022.
- The 4-year median for Gains from Sales and Divestitures is $1.4 million (2023), against an average of $1.6 million.
- Peak YoY movement for Gains from Sales and Divestitures: soared 34.19% in 2024, then crashed 47.2% in 2025.
- Tracing ASPI's Gains from Sales and Divestitures over 4 years: stood at $350000.0 in 2022, then surged by 568.82% to $2.3 million in 2023, then soared by 65.45% to $3.9 million in 2024, then decreased by 24.59% to $2.9 million in 2025.
- According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $2.9 million, $984330.0, and $457115.0 for Q4 2025, Q2 2025, and Q1 2025 respectively.